wróć do listy

REVISTA EXELEON DR. SERRANO

REVISTA EXELEON DR. SERRANO

SESDERMA World Media PRESS INFORMATIONS

REVISTA EXELEON DR. SERRANO 

“SESDERMA IS A LEADING DERMATOLOGICAL LABORATORY WITH A GLOBAL FOOTPRINT IN OVER 85 COUNTRIES ACROSS THE WORLD.”

INNOVATION AND TECHNOLOGICAL BREAKTHROUGHS

Dr. Serrano's journey in dermatology reflects the evolution of the field itself. Over four decades ago, dermo-cosmetics was in its infancy, and Dr. Serrano actively participated in the development of procedures and substances used in various dermatological treatments. His role in advancing chemical peels and substances for mesotherapy contributed to the establishment of Mediderma, a leader in treatments for medical professionals. One of his notable achievements was the development of Nomelan Fenol, a safe and non-sedative formula for a phenol chemical peel. This breakthrough eliminated the need for hospitalization and sedation traditionally associated with phenol peels, making the treatment more accessible and safer for patients. The cosmetic industry has undergone significant transformations in the past three decades. Dr. Serrano highlights the shift from limited options to a diverse range of skincare products formulated with pH balance, carefully selected active ingredients, and skin-friendly fragrances. Nanotechnology, representing the future of cosmetics, explores the potential of growth factors, stem cells, and cutting-edge technologies. Presently, the company continues to work with topical agents, such as the various forms of retinol, peptides, dermal dillers, or botox-like ingredients, plus all microneedling devices, radiofrequency, and similar treatments in order to embrace the passage of time instead of sighting it. That is the essence of the pro-aging concept, a change of perspective that is gaining relevance in skin care and that promotes naturalness, first and foremost. In addition to the above, Sesderma is researching and developing solutions with exosomes. “These act as messengers and are responsible for intracellular communication, which means they send information to damaged cells so that they can function better, regenerating and rejuvenating the skin. In fact, they are already being used in combination with microneedling treatments from Mediderma, our division for professional products and medical-aesthetic use. We also incorporated exosomes in the formulation of dermo-cosmetic products of Sesderma,” the team explains. VISION FOR THE FUTURE As the founder and visionary behind Sesderma Laboratories, Dr. Serrano has not only redefined the possibilities of skincare but has also instilled a culture of humanity, generosity, and innovation within the company. Dr. Gabriel Serrano's legacy extends far beyond his current achievements. Over the last 40 years, he has pioneered nanotechnology in dermocosmetics, internationalized Sesderma, established a modern production site in Valencia, and committed to philanthropic endeavors through the Sesderma-Bali Foundation. Sesderma's future, as envisioned by Dr. Serrano, involves further international expansion and maintaining leadership in its markets. The company's commitment to prioritizing consumers and patients, coupled with bold investments in innovation, underscores its continuous growth and evolution

80002941 ENG REVISTA EXELEON DR. SERRANO-low.pdf